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Abstract
Background: Bombina variegate peptide 8 (Bv8) is a small protein secreted by frog skin. Recently
it has been shown to contribute to tumor angiogenesis in mouse model. The purpose of this study
was to investigate Bv8 in mice with type II collagen-induced arthritis (CIA).
Methods: We induced CIA in male DBA/1J mice. The severity of arthritis was evaluated based on
an arthritis score. RNA was extracted from the joint, and examined for Bv8 mRNA expression by
RT-PCR and real-time RT-PCR. Synovial tissue and bone marrow were immunohistochemically
examined using anti-Bv8 antibody.
Results: The level of Bv8 mRNA expression in the joint was below the detection limit in the
control group, but was elevated in the CIA group, and was correlated with the arthritis score. In
addition, an increase in Bv8-positive cells was observed in the synovium and bone marrow in the
CIA group.
Conclusion: Bv8 was elevated in the synovium and bone marrow of CIA mice, suggesting that Bv8
plays an important role in the pathogenesis of arthritis.
Background
Bombina variegata peptide 8 (Bv8)/prokineticin-2 is a pro-
tein isolated from skin secretions of the frog Bombina var-
iegata [1,2]. Endocrine gland-derived VEGF, also known
as prokineticin-1, belongs to the same family as Bv8[3].
Bv8 has diverse functions, being involved in angiogenesis,
gastrointestinal motility, neurogenesis, circadian rhythm
regulation, hormone release, and the pain threshold [4,5].
Recently, Ferrara et al. reported an interesting study on
angiogenesis: tumor-derived granulocyte colony-stimulat-
ing factor (G-CSF) mobilized bone marrow Bv8-positive
cells to tumor sites, and these cells were CD11b+/Gr1+,
promoting tumor angiogenesis via the mediation of
Bv8[6]. On the other hand, angiogenesis is closely
involved in the pathogenesis of type II collagen-induced
arthritis (CIA), a model of rheumatoid arthritis [7,8]. In
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addition, an increase in CD11b+/Gr1+ cells was reported
in the joints of CIA mice [9,10]. These observations sug-
gest that Bv8 is involved in the pathogenesis of arthritis in
CIA mice. Therefore, in this study, we investigated Bv8 in
CIA mice.
Methods
Induction of arthritis in mice
All animal experiments were performed according to the
Guidelines on Animal Experimentation of the Jikei Uni-
versity School of Medicine. Five-week-old male DBA/1J
mice were purchased from Kyudo Ltd. (Fukuoka, Japan),
and used after an acclimatization period of 1 week
together as a group. Collagen-induced arthritis was
induced as follows.[8] A 0.3% solution of bovine type II
collagen(Cosmo Bio Co., Ltd., Tokyo, Japan) was emulsi-
fied in an equal volume of complete Freund's adjuvant
(Difco Laboratories, Detroit, MI, USA). One hundred
microlitres of this emulsion was injected intradermally
into the dorsal root of the tail of 6-week-old male DBA/1J
mice. This day was defined as day 0. Before arthritis onset,
the mice received a booster injection of 0.3% bovine type
II collagen solution emulsified in incomplete Freund's
adjuvant on day 21, as described above for the primary
injection. We used non-immunized mice as a control.
Each experimental group consisted of five mice. mRNA
analysis was performed twice, and the reproducibility was
confirmed.
Macroscopic evaluation of arthritis
The severity of arthritis was evaluated by the sum of the
score for each wrist and ankle joint based on the following
arthritis scale: 0, normal; 1, swelling of digits alone or
mild swelling of wrist and ankle joints; 2, clear swelling of
wrist and ankle joints; and 3, ankylosis or deformity of
wrist and ankle joints.
RNA extraction from joints
Mice were sacrificed under diethyl ether inhalation
anesthesia on days 21, 24, 28, and 35 after the first immu-
nization, and the fore- and hindlimbs were amputated 5
mm proximal to the wrist and ankle joints, respectively.
Correlation between the arthritis score and Bv8 mRNA expression Figure 1
Correlation between the arthritis score and Bv8 mRNA expression. One group consisted of 5 mice. b shows the 
results of analysis by RT-PCR. c and d show the results of analysis by real-time PCR. The relative expression of Bv8 and VEGF 
mRNA was standardized to that of GAPDH mRNA. The results are expressed relative to day 21 CIA mice, arbitrarily assigned 
a value of 1.0. a. Changes in the arthritis score. b. Comparison of Bv8 mRNA expression in joint tissue on day 28 between the 
CIA and control groups. c. Bv8 mRNA expression in arthritic joints on days 21, 24, 28, and 35. d. VEGF mRNA expression in 
arthritic joints on days 21, 24, 28, and 35.
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RNA was extracted using ISOGEN (Nippon Gene Co.,
Ltd., Tokyo, Japan).
RT-PCR
cDNA was synthesized using SuperScript™ II Reverse Tran-
scriptase (Invitrogen, Tokyo, Japan). PCR was performed
employing Gene Amp PCR System 9700 (Applied Biosys-
tems, Foster City, CA, USA) using Ampli Taq Gold
(Applied Biosystems, Foster City, CA, USA). Testis-derived
RNA was used as a control. The primers used for Bv8 and
GAPDH were as follows: Bv8, 5'-AGAGGAAGAAGGAG-
GTTC-3' and 5'-GAGTAAGGGTGTGTCTGTCT-3'; and
GAPDH, 5'-TCACCATCTTCCAGGAGCG-3' and 5'-
CTGCTTCACCACCTTCTTGA-3'.
Real-time RT-PCR
cDNA was synthesized using a QuantiTect Reverse Tran-
scription Kit (Qiagen K.K., Tokyo, Japan). Real-time PCR
was performed in an ABI PRISM Sequence Detection Sys-
tem (Applied Biosystems, Foster City, CA, USA) using a
QuantiTect SYBR Green PCR Kit (Qiagen K.K., Tokyo,
Japan) and Quantitect Primer Assay (Mm Prok2 1 SG
Quantitect Primer Assay, Mm Gapd 1 SG Quantitect
Primer Assay and Mm vegfa 1 SG Quantitect Primer Assay;
Qiagen K.K., Tokyo, Japan). The results were analyzed
using the ΔΔCt method.
Histological evaluation
On day 28, mice were anesthetized by an intraperitoneal
injection of pentobarbital, followed by perfusion fixation
with 4% paraformaldehyde. Subsequently, the fore- and
hindlimbs were amputated 5 mm proximal to the wrist
and ankle joints, respectively, and were immersion-fixed
in 4% paraformaldehyde at 4°C for 2 days. The fixed
limbs were delipidated with 100% ethanol at 4°C for 1
day, and then decalcified with EDTA at room temperature
for 3 days. Thin sections were stained with H and E, and
immunostained with anti-prokineticin 2 and anti Gr-1
antibodies. Thin paraffin sections were deparaffinized
with xylene, and the xylene was removed with 100% eth-
anol. To activate the antigen, sections were incubated in 1
mM sodium citrate buffer at 98°C for 2 h. Endogenous
peroxidase in sections was inactivated with a peroxidase-
blocking reagent (Dako Cytomation Co., Ltd., Kyoto,
Japan). The sections were washed with PBS, blocked with
10% normal rabbit serum, and incubated with the pri-
Histopathological examination of the synovium Figure 2
Histopathological examination of the synovium. Bv8 in Figs. d, e, and f was stained brown. a. HE-staining of the syn-
ovium in the control group (×200). b. HE-staining of the synovium in the CIA group (×50). c. HE-staining of the synovium in the 
CIA group (×200). The area in the box in Fig. b is enlarged. d. Immunohistochemical staining of the synovium with anti-Bv8 
antibody in the control group (×200). e. Immunohistochemical staining of the synovium with anti-Bv8 antibody in the CIA 
group (×50). f. Immunohistochemical staining of the synovium with anti-Bv8 antibody in the CIA group (×200). The area in the 
box in Fig. e is enlarged.
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mary antibody, a 1:200 dilution of goat anti-mouse prok-
ineticin 2 antibody (Santa Cruz Biotechnology, Inc., Santa
Cruz, CA, USA), at 4°C overnight, and washed with PBS.
Subsequently, the sections were reacted with Simple Stain
MAX-PO(G) (Nichirei Bioscience Inc., Tokyo, Japan) as
the secondary antibody at room temperature for 30 min,
and washed with PBS. The color was developed by the
addition of Simple Stain DAB Solution (Nichirei Bio-
science Inc., Tokyo, Japan) for 10 min at room tempera-
ture. The sections were finally counterstained with
hematoxylin. For Gr-1 staining, the sections were incu-
bated with primary antibody, a 1:100 dulution of rat anti-
mouse Gr-1 antibody (Becton, Dickinson and Co., Tokyo,
Japan), at 4°C overnight, and reacted with biotin-conju-
gated rabbit anti-rat IgG antibody (Dako Cytomation Co.,
Ltd., Kyoto, Japan) and ALP-labeled streptavidin (Nichirei
Bioscience Inc., Tokyo, Japan). The color was developed
by the addition of Vector Blue(Vector Laboratories, Inc.,
CA, USA)for 45 min at room temperature.
Statistical analysis
Data obtained by real-time PCR were analyzed using the
Mann-Whitney U-test. A p-value of less than 0.05 was
considered significant.
Histopathological examination of bone marrow in the distal tibia Figure 3
Histopathological examination of bone marrow in the distal tibia. In Figs. e and f, Bv8 was stained brown. a. HE-stain-
ing of bone marrow in the control group (×50). b. HE-staining of bone marrow in the CIA group (×50). c. HE-staining of bone 
marrow in the control group (×200). The area in the box in Fig. a is enlarged. d. HE-staining of bone marrow in the CIA group 
(×200). The area in the box in Fig. b is enlarged. e. Immunohistochemical staining of bone marrow with anti-Bv8 antibody in the 
control group (×200). f. Immunohistochemical staining of bone marrow with anti-Bv8 antibody in the CIA group (×200).
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Results
Mice developed CIA 2–3 days after the booster injection
(on day 21). The severity of arthritis peaked on approxi-
mately day 30 (Fig. 1a). RNA was extracted from the joint
on days 21, 24, 28, and 35, and was analyzed for Bv8
mRNA expression. On day 28, Bv8 mRNA expression was
detectable by RT-PCR in 4 of the 5 CIA mice, but was
below the detection limit in all control mice (Fig. 1b).
Similar results were obtained in the CIA and control mice
sacrificed on day 35 (data not shown). It is of note that
Bv8 mRNA expression could not be detected in the RNA
of CIA mice with minimal arthritis. Next, changes in Bv8
mRNA expression were analyzed by real-time RT-PCR
(Fig. 1c). The level of Bv8 expression increased rapidly
from day 28, and tended to decrease gradually thereafter.
The time course of Bv8 mRNA expression roughly paral-
leled the arthritis score. Mann-Whitney U-test analysis
showed significant differences in the Bv8 mRNA expres-
sion level between the mice sacrificed on days 21 and 28.
The expression of mRNA for VEGF, an angiogenesis-pro-
moting factor, was similarly analyzed. The level of VEGF
expression was slightly higher on days 28 and 35 than on
day 21 (Fig. 1d). The relative VEGF mRNA expression level
was 1.39, as compared to 5.75 for Bv8, indicating that the
rate of increase in Bv8 was higher than that in VEGF in
arthritis. Next, to analyze Bv8 expression at the protein
level, we examined synovial tissue and bone marrow
immunohistochemically using anti-Bv8 antibody(Figs. 2,
3). Bv8-positive cells were observed in the superficial layer
of the normal synovium (Fig. 2d), but were clearly
increased in the arthritic pannus (Fig. 2e, f). Morphologi-
cally, most Bv8-positive cells were macrophage-like,
although some of them could not be clearly identified. In
addition, Bv8-positive cells were observed in the normal
bone marrow of the distal tibia as well(Fig. 3e), but were
markedly increased in the bone marrow of CIA mice(Fig.
3f). Morphologically, Bv8-positive cells were predomi-
nantly myeloid-lineage cells(Fig. 3c, d). To characterize
Bv8-positive cells in more detail, arthritic joints were dou-
ble-stained with anti-Bv8 and anti-Gr-1 antibodies. Most
Bv8-positive cells observed in arthritic synovia were also
positive for Gr-1 (Fig. 4).
Discussion
The development of arthritis was associated with elevated
Bv8 mRNA expression in the arthritic joint of CIA mice.
Histopathologically, Bv8-positive cells were increased in
the synovium and bone marrow. These results suggest that
Bv8 is involved in the pathogenesis of arthritis. Further,
the time course of changes in the expression of mRNA for
VEGF, a potent angiogenesis-promoting factor, paralleled
that in the expression of Bv8 mRNA. VEGF is known to
play an important role in angiogenesis in inflamed syno-
via. The similar behavior of both factors in arthritis sug-
gests the possible involvement of Bv8 as well as VEGF in
angiogenesis in inflamed synovia. In this study, the rate of
increase in Bv8 was higher than that in VEGF in arthritis.
In normal joints, Bv8 is expressed very weakly, but VEGF
expression is higher, which may explain the higher rate of
increase in Bv8. In addition to being involved in angio-
genesis, Bv8 has diverse functions, including circadian
rhythm regulation[11]. Patients with rheumatoid arthritis
exhibit an abnormal circadian rhythm[12], which has also
been reported in a rat model of arthritis [13,14]. There-
fore, Bv8 may be involved in arthritis pathogenesis. Fer-
rara et al. reported Bv8-expressing CD11b+/Gr1+ cells
[6.15]. On the other hand, these cells have been shown to
be increased in arthritic joints and peripheral tissue in
arthritis models [9,10]. These observations strongly sug-
gested that the Bv8-positive cells in the present study cor-
responded to CD11b+/Gr1+ cells. Therefore, we
attempted to clarify this point, and found that the Bv8-
positve cells in the synovium were positively immunos-
tained with anti-Gr1 antibody; however, we could not
detect the presence of CD11b in them. Since the tissue sec-
tions under study contained osseous and cartilaginous tis-
sue requiring prolonged decalcification, it was necessary
to prevent antigen denaturation by employing a fixation
procedure. Only anti-CD11b antibody for frozen sections
was available, which may have affected the analysis of
CD11b expression. This point requires further study.
G-CSF has been reported to increase Bv8 expression in
bone marrow CD11b+/Gr1+ cells, and to be important
when Bv8-positive cells are mobilized to tumor tissue
[6.16]. G-CSF is closely involved in the pathogenesis of
arthritis as well[17]. Therefore, bone marrow CD11b+/
Gr1+ cells may be mobilized to arthritic synovial tissue.
On the other hand, some Bv8-positive cells were noted in
Immunohistochemical staining of the synovium with anti-Bv8  and anti-Gr-1 antibodies in the CIA group (×400) Figure 4
Immunohistochemical staining of the synovium with 
anti-Bv8 and anti-Gr-1 antibodies in the CIA group 
(×400). Bv8 and Gr-1 were stained brown and red, respec-
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normal synovial tissue. Further studies are necessary to
determine what percentage of the Bv8-positive cells that
were increased in arthritic synovial tissue were derived
from the bone marrow.
Conclusion
In this study, we demonstrated increased Bv8 expression
in the synovium and bone marrow of CIA mice. Further
studies are needed to clarify how theses changes are
involved in the pathogenesis of arthritis.
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